Adracalin antibody
Quick Overview for Adracalin antibody (ABIN7111183)
Target
See all Adracalin (AAAS) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- AAAS antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple-A)
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500 - 1:2000, IHC: 1:50 - 1:200, IF: 1:50 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- Adracalin (AAAS) (Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS))
-
Alternative Name
- AAAS
-
Background
-
Synonyms: Aladin|Adracalin|AAAS|ADRACALA
Background: The protein encoded by this gene is a member of the WD-repeat family of regulatory proteins and may be involved in normal development of the peripheral and central nervous system. The encoded protein is part of the nuclear pore complex and is anchored there by NDC1. Defects in this gene are a cause of achalasia-addisonianism-alacrima syndrome (AAAS), also called triple-A syndrome or Allgrove syndrome. Two transcript variants encoding different isoforms have been found for this gene.
-
Molecular Weight
- 60 kDa
-
Gene ID
- 8086
-
UniProt
- Q9NRG9
Target
-